Increasing Attention to Prostate Cancer

Publication
Article
OncologyONCOLOGY Vol 15 No 4
Volume 15
Issue 4

A new bill called the Men’s Health Act of 2001 aims to focus more attention on diagnosing and treating men with prostate cancer. Rep. Randy Cunningham’s (R-Calif) Men’s Health

A new bill called the Men’s Health Act of 2001 aims to focusmoreattention on diagnosing and treating men with prostate cancer.Rep. Randy Cunningham’s (R-Calif) Men’s Health Act of 2001 doesn’texplicitly require that anything be done; it simply would establish an Office ofMen’s Health within the Public Health Service. (There is already a Women’sHealth Office.) 

The intentions of the bill (H.R. 632) are made clear byreferences to prostate cancer and, to a lesser extent, testicular cancer—theonly two diseases mentioned with emphasis. The Men’s Health Office would haveto send recommendations to Congress within 2 years of its establishment.

Recent Videos
Biochemical markers and advanced imaging modalities play a critical role in monitoring patients undergoing RLT therapy for metastatic prostate cancer.
Data support the use of radioligand therapy in combination with androgen receptor pathway inhibitors to optimize prostate cancer outcomes.
Experts weigh in on tumor-informed testing, false positives, relevant trial data, and other key concepts related to circulating tumor DNA.
Ongoing studies in kidney cancer aim to explore determinants of immune-related adverse effects and strategies for mitigating them.
Machine learning-based approaches may play a role in further understanding of how somatic alterations influence responses or resistance to therapy.
Data from a first-in-disease trial assessing a personalized cancer vaccine in RCC require validation at a larger level, according to David Braun, MD, PhD.
Experts highlight methods for optimally treating patients with genitourinary cancers harboring variant histologies at World GU 2025.
Related Content